{"id":8618,"date":"2023-01-13T10:12:00","date_gmt":"2023-01-13T10:12:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=8618"},"modified":"2024-04-30T14:06:38","modified_gmt":"2024-04-30T12:06:38","slug":"concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/","title":{"rendered":"Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Ueno+N&amp;cauthor_id=36636880\">Nobuhiro Ueno<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Sugiyama+Y&amp;cauthor_id=36636880\">Yuya Sugiyama<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kobayashi+Y&amp;cauthor_id=36636880\">Yu Kobayashi<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Murakami+Y&amp;cauthor_id=36636880\">Yuki Murakami<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Iwama+T&amp;cauthor_id=36636880\">Takuya Iwama<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-2\">2<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Sasaki+T&amp;cauthor_id=36636880\">Takahiro Sasaki<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kunogi+T&amp;cauthor_id=36636880\">Takehito Kunogi<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Sakatani+A&amp;cauthor_id=36636880\">Aki Sakatani<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Takahashi+K&amp;cauthor_id=36636880\">Keitaro Takahashi<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Tanaka+K&amp;cauthor_id=36636880\">Kazuyuki Tanaka<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-3\">3<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Serikawa+S&amp;cauthor_id=36636880\">Shinya Serikawa<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-4\">4<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Ando+K&amp;cauthor_id=36636880\">Katsuyoshi Ando<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kashima+S&amp;cauthor_id=36636880\">Shin Kashima<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Muto+M&amp;cauthor_id=36636880\">Momotaro Muto<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-5\">5<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Inaba+Y&amp;cauthor_id=36636880\">Yuhei Inaba<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-2\">2<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Moriichi+K&amp;cauthor_id=36636880\">Kentaro Moriichi<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Tanabe+H&amp;cauthor_id=36636880\">Hiroki Tanabe<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Okumura+T&amp;cauthor_id=36636880\">Toshikatsu Okumura<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Fujiya+M&amp;cauthor_id=36636880\">Mikihiro Fujiya<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>J Clin Apher. \u00a02023 Jan 13.\u00a0doi: 10.1002\/jca.22040.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Background:\u00a0<\/strong>Granulocyte and monocyte adsorptive apheresis (GMA) with Adacolumn has been used as a remission induction therapy for patients with active ulcerative colitis (UC). Herein, we investigated the influence of concomitant medications in the remission induction of GMA in patients with active UC. <strong>Methods:\u00a0<\/strong>This multicenter retrospective cohort study included patients with UC underwent GMA in five independent institutions in Japan from January 2011 to July 2021. Factors including concomitant medications associated with clinical remission (CR) were analyzed statistically. <strong>Result:\u00a0<\/strong>A total of 133 patients were included. Seventy-four patients achieved a CR after GMA. The multivariable analysis revealed that concomitant medication with 5-aminosalicylic acid, Mayo endoscopic subscore (MES), and concomitant medication with immunosuppressors (IMs) remained as predictors of CR after GMA. In the subgroup analysis in patients with MES of 2, concomitant medication with IMs was demonstrated as a significant negative factor of CR after GMA (P = .042, OR 0.354). Seventy-four patients who achieved CR after GMA were followed up for 52 weeks. In the multivariable analysis, the maintenance therapy with IMs was demonstrated as a significant positive factor of sustained CR up to 52 weeks (P = .038, OR 2.214). Furthermore, the rate of sustained CR in patients with biologics and IMs was significantly higher than that in patients with biologics only (P = .002). <strong>Conclusion:\u00a0<\/strong>GMA was more effective for patients with active UC that relapsed under treatment without IMs. Furthermore, the addition of IMs should be considered in patients on maintenance therapy with biologics after GMA.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36636880\/\" target=\"_blank\" rel=\"noreferrer noopener\">Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study &#8211; PubMed (nih.gov)<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=%22J+Clin+Apher%22%5Bjour%5D&amp;sort_order=desc\"><\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Nobuhiro Ueno\u00a01,\u00a0Yuya Sugiyama\u00a01,\u00a0Yu Kobayashi\u00a01,\u00a0Yuki Murakami\u00a01,\u00a0Takuya Iwama\u00a02,\u00a0Takahiro Sasaki\u00a01,\u00a0Takehito Kunogi\u00a01,\u00a0Aki Sakatani\u00a01,\u00a0Keitaro Takahashi\u00a01,\u00a0Kazuyuki Tanaka\u00a03,\u00a0Shinya Serikawa\u00a04,\u00a0Katsuyoshi Ando\u00a01,\u00a0Shin Kashima\u00a01,\u00a0Momotaro Muto\u00a05,\u00a0Yuhei Inaba\u00a02,\u00a0Kentaro Moriichi\u00a01,\u00a0Hiroki Tanabe\u00a01,\u00a0Toshikatsu Okumura\u00a01,\u00a0Mikihiro Fujiya J Clin Apher. \u00a02023 Jan 13.\u00a0doi: 10.1002\/jca.22040. Background:\u00a0Granulocyte and monocyte adsorptive apheresis (GMA) with Adacolumn has been used as a remission induction therapy for patients with active ulcerative colitis (UC). Herein, we investigated the influence [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[721,134,346,720,424,133,100,305,271,306],"class_list":["post-8618","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-5-asa","scientific_tags-biologics","scientific_tags-cohort","scientific_tags-concomitant-drugs","scientific_tags-gma","scientific_tags-immunosuppressants","scientific_tags-multicenter","scientific_tags-retrsopective","scientific_tags-study","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Nobuhiro Ueno\u00a01,\u00a0Yuya Sugiyama\u00a01,\u00a0Yu Kobayashi\u00a01,\u00a0Yuki Murakami\u00a01,\u00a0Takuya Iwama\u00a02,\u00a0Takahiro Sasaki\u00a01,\u00a0Takehito Kunogi\u00a01,\u00a0Aki Sakatani\u00a01,\u00a0Keitaro Takahashi\u00a01,\u00a0Kazuyuki Tanaka\u00a03,\u00a0Shinya Serikawa\u00a04,\u00a0Katsuyoshi Ando\u00a01,\u00a0Shin Kashima\u00a01,\u00a0Momotaro Muto\u00a05,\u00a0Yuhei Inaba\u00a02,\u00a0Kentaro Moriichi\u00a01,\u00a0Hiroki Tanabe\u00a01,\u00a0Toshikatsu Okumura\u00a01,\u00a0Mikihiro Fujiya J Clin Apher. \u00a02023 Jan 13.\u00a0doi: 10.1002\/jca.22040. Background:\u00a0Granulocyte and monocyte adsorptive apheresis (GMA) with Adacolumn has been used as a remission induction therapy for patients with active ulcerative colitis (UC). Herein, we investigated the influence [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-30T12:06:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/\",\"name\":\"Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2023-01-13T10:12:00+00:00\",\"dateModified\":\"2024-04-30T12:06:38+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/","og_locale":"es_ES","og_type":"article","og_title":"Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study - Adacyte","og_description":"Nobuhiro Ueno\u00a01,\u00a0Yuya Sugiyama\u00a01,\u00a0Yu Kobayashi\u00a01,\u00a0Yuki Murakami\u00a01,\u00a0Takuya Iwama\u00a02,\u00a0Takahiro Sasaki\u00a01,\u00a0Takehito Kunogi\u00a01,\u00a0Aki Sakatani\u00a01,\u00a0Keitaro Takahashi\u00a01,\u00a0Kazuyuki Tanaka\u00a03,\u00a0Shinya Serikawa\u00a04,\u00a0Katsuyoshi Ando\u00a01,\u00a0Shin Kashima\u00a01,\u00a0Momotaro Muto\u00a05,\u00a0Yuhei Inaba\u00a02,\u00a0Kentaro Moriichi\u00a01,\u00a0Hiroki Tanabe\u00a01,\u00a0Toshikatsu Okumura\u00a01,\u00a0Mikihiro Fujiya J Clin Apher. \u00a02023 Jan 13.\u00a0doi: 10.1002\/jca.22040. Background:\u00a0Granulocyte and monocyte adsorptive apheresis (GMA) with Adacolumn has been used as a remission induction therapy for patients with active ulcerative colitis (UC). Herein, we investigated the influence [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/","og_site_name":"Adacyte","article_modified_time":"2024-04-30T12:06:38+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/","name":"Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2023-01-13T10:12:00+00:00","dateModified":"2024-04-30T12:06:38+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/concomitant-pharmacologic-medications-influence-the-clinical-outcomes-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-ulcerative-colitis-a-multicenter-retrospective-cohort-study\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/8618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=8618"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=8618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}